subscribeSubscribe
price-trendAsk Us
Withdrawal of marketing authorisations for fenspiride medicines

Withdrawal of marketing authorisations for fenspiride medicines
EMA
29 May 2019
Share Share
EMA’s PRAC Calls for Withdrawal of Fenspiride CoughMedicines,Restrict on Xeljanz

EMA’s PRAC Calls for Withdrawal of Fenspiride CoughMedicines,Restrict on Xeljanz
Nick Paul Taylor RAPS
23 May 2019
Share Share
Withdrawal of marketing authorisations for fenspiride medicines

Withdrawal of marketing authorisations for fenspiride medicines

EMA
18 May 2019
Share Share
EMA suspends fenspiride medicines due to heart rhythm risks

EMA suspends fenspiride medicines due to heart rhythm risks
Anna Smith PHARMA TIMES
19 Feb 2019
Share Share
Meeting highlights from PV Risk Assessment Committee 11-14 Feb 2019

Meeting highlights from PV Risk Assessment Committee 11-14 Feb 2019
EMA
15 Feb 2019
Share Share
Suspension of fenspiride medicines due to risk of heart rhythm problems

Suspension of fenspiride medicines due to risk of heart rhythm problems
EMA
15 Feb 2019
Share Share